Cost-Effectiveness of Combination Disease-Modifying Antirheumatics vs. Tumour Necrosis Factor Inhibitors in Active Rheumatoid Arthritis: TACIT Trial
Arthritis Care and Research - United States
doi 10.1002/acr.23830
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 27, 2020
Authors
Publisher
Wiley